TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Syncona Shs GBP ( (GB:SYNC) ) has issued an announcement.
Syncona Limited announced the issuance of 334,788 new ordinary shares as part of its long-term incentive scheme, representing approximately 0.055% of its existing shares. These shares, which will be issued at a price of £0.996 per share, are subject to a one-year holding period before they can be sold or transferred. The shares are expected to be admitted to the Official List and begin trading on the London Stock Exchange on 20 November 2025, reflecting Syncona’s commitment to rewarding its stakeholders and aligning with its strategic growth initiatives.
The most recent analyst rating on (GB:SYNC) stock is a Buy with a £1.70 price target. To see the full list of analyst forecasts on Syncona Shs GBP stock, see the GB:SYNC Stock Forecast page.
Spark’s Take on GB:SYNC Stock
According to Spark, TipRanks’ AI Analyst, GB:SYNC is a Neutral.
Syncona Shs GBP exhibits financial stability with a solid balance sheet and improved cash flow. However, revenue volatility and negative valuation metrics are significant challenges. The technical indicators suggest bearish trends, but the strategic share buyback program provides some positive momentum. Despite these strengths, valuation concerns and market challenges contribute to a mixed outlook.
To see Spark’s full report on GB:SYNC stock, click here.
More about Syncona Shs GBP
Syncona Limited is a leading life science investor, focusing on building and funding companies in the healthcare sector. The company is involved in creating and growing businesses that develop innovative treatments and technologies in the life sciences industry.
Average Trading Volume: 549,685
Technical Sentiment Signal: Sell
Learn more about SYNC stock on TipRanks’ Stock Analysis page.

